Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: SSL-built satellite Satmex 8 successfully performs post-launch maneuvers to St. Jude Medical First to Receive CE Mark Approval of Deep Brain Stimulation Systems for Both Primary and Secondary Dystonia

This site contains about 74,006 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   1,000   1,100   1,200   1,300   1,400   1,500   1,600   1,700   1,800   1,910   1,920   1,930   1,940   1,950   1,960   1,970   1,980   1,990   1,999   2,000   2,001   2,002   2,003   2,004   2,005   2,006   2,007   2,008   2,009   2,010   2,011   2,012   2,013   2,014   2,015   2,016   2,017   2,018   2,019   2,020   2,021   2,022   2,023   2,024   2,025   2,026   2,027   2,028   2,030   2,040   2,050   2,060   2,070   2,080   2,090   2,100   2,110   2,200   2,300   2,400   2,467 

2013/3/27
SSL-built satellite Satmex 8 successfully performs post-launch maneuvers
SSL-built satellite Satmex 8 successfully performs post-launch maneuvers Canada NewsWire PALO ALTO , CA, March 27, 2013 /CNW/ - Space Systems/Loral (SSL), a leading provider of commercial satellites, today announced that the Satmex 8 satellite, designed and built for Satélites Mexicanos, S.A. de C.V. (Satmex), was launched yesterday and is successfully performing post-launch maneuvers according to plan.
View more SSL-built satellite Satmex 8 successfully performs post-launch maneuvers analysis
Sign-up for SSL-built satellite Satmex 8 successfully performs post-launch maneuvers investment picks
2013/4/5
SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence
SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence Canada NewsWire Leading Canadian financial and insurance company completes first phase of communications software deployment to consolidate infrastructure and add functionality INDIANAPOLIS , IN and QUEBEC CITY, April 5, 2013 /CNW Telbec/ - SSQ Financial Group, one of Canada's largest financial and insurance institutions, has consolidated its communications infrastructure and added functionality as a result of deploying unified IP business communications software from Interactive Intelligence Group Inc. (Nasdaq: ININ) .
View more SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence analysis
Sign-up for SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence investment picks
2013/4/5
SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence
SSQ Financial Group, one of Canada’s largest financial and insurance institutions, has consolidated its communications infrastructure and added functionality as a result of deploying unified IP business communications software from Interactive Intelligence Group Inc. (Nasdaq: ININ) .
View more SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence analysis
Sign-up for SSQ Financial Group Deploys Unified IP Business Communications Software from Interactive Intelligence investment picks
2013/3/12
ST and Thingsquare Team Up to Advance Easy-to-Use Internet of Things
http://media.marketwire.com/attachments/201207/66682_logostm.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=995624&ProfileId=051205&sourceType=1 STOCKHOLM, SWEDEN and GENEVA --
View more ST and Thingsquare Team Up to Advance Easy-to-Use Internet of Things analysis
Sign-up for ST and Thingsquare Team Up to Advance Easy-to-Use Internet of Things investment picks
2013/5/28
ST-Ericsson Sells GNSS Business's Assets, Property Rights
ST-Ericsson, a joint venture between computer chip maker STMicroelectronics NV (STM.FR) and Sweden's Ericsson (ERIC), Tuesday said it has sold assets and intellectual property rights associated to its mobile connectivity global navigation satellite system business.
View more ST-Ericsson Sells GNSS Business's Assets, Property Rights analysis
Sign-up for ST-Ericsson Sells GNSS Business's Assets, Property Rights investment picks
2013/4/29
St. Boniface Haiti Foundation Honored With athenahealth 2013 Vision Award
WATERTOWN, Mass., April 29, 2013 (GLOBE NEWSWIRE) -- athenahealth, Inc. (Nasdaq:ATHN) , a leading provider of cloud-based services for electronic health record ( EHR ), practice management, and care coordination , today announced the St.
View more St. Boniface Haiti Foundation Honored With athenahealth 2013 Vision Award analysis
Sign-up for St. Boniface Haiti Foundation Honored With athenahealth 2013 Vision Award investment picks
2013/5/8
St. Catharines Roma U12 Girls Selected as Fourth BMO Team of the Week for 2013
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0872099001&sourceType=1 http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif http://media3.marketwire.com/logos/20120605-bmoteam2.jpg http://www.marketwire.com/library/20130507-stcatharinesroma300.jpg Congratulations to St.
View more St. Catharines Roma U12 Girls Selected as Fourth BMO Team of the Week for 2013 analysis
Sign-up for St. Catharines Roma U12 Girls Selected as Fourth BMO Team of the Week for 2013 investment picks
2013/5/15
St. Joe Signs a Letter of Intent with Green Circle Bio Energy to Encourage Economic Development Opportunities in Northwest Florida
The St.
View more St. Joe Signs a Letter of Intent with Green Circle Bio Energy to Encourage Economic Development Opportunities in Northwest Florida analysis
Sign-up for St. Joe Signs a Letter of Intent with Green Circle Bio Energy to Encourage Economic Development Opportunities in Northwest Florida investment picks
2013/4/9
St. John's Research Institute Honored by Waters Center of Innovation Program
Structural Proteomics Laboratory Directed by Prof.
View more St. John's Research Institute Honored by Waters Center of Innovation Program analysis
Sign-up for St. John's Research Institute Honored by Waters Center of Innovation Program investment picks
2013/4/9
St. Joseph, Inc. Announces Completion of Due Diligence of Domestic Telecom Interests
St. Joseph, Inc. (OTCBB: STJO) is pleased to announce it has completed an in-depth due diligence in connection with the acquisition of interests in a domestic telecommunication company as described in prior news announcements.
View more St. Joseph, Inc. Announces Completion of Due Diligence of Domestic Telecom Interests analysis
Sign-up for St. Joseph, Inc. Announces Completion of Due Diligence of Domestic Telecom Interests investment picks
2013/5/10
St. Joseph, Inc. Provides Update on Reverse Acquisition
St. Joseph, Inc. (OTCBB: STJO) discloses Zone USA, Inc. as its candidate for reverse takeover.
View more St. Joseph, Inc. Provides Update on Reverse Acquisition analysis
Sign-up for St. Joseph, Inc. Provides Update on Reverse Acquisition investment picks
2013/5/21
St. Joseph's Imaging Associates Selects Merge's Radiology Suite
CHICAGO, May 21, 2013 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE) , a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that St.
View more St. Joseph's Imaging Associates Selects Merge's Radiology Suite analysis
Sign-up for St. Joseph's Imaging Associates Selects Merge's Radiology Suite investment picks
2013/6/7
St. Jude Invests in Spinal Modulation; Gains Option to Acquire Company
St. Jude Medical Inc. (STJ) has agreed to invest $40 million in a privately held medical device company that developed a new pain management therapy, gaining the right to exclusively distribute the system and potentially acquire the company.
View more St. Jude Invests in Spinal Modulation; Gains Option to Acquire Company analysis
Sign-up for St. Jude Invests in Spinal Modulation; Gains Option to Acquire Company investment picks
2013/4/17
St. Jude Medical 1st-Quarter Profit Rose 5.2% as Lower Costs Offset Revenue Decline
St. Jude Medical Inc.'s (STJ) first-quarter earnings rose 5.2% as lower costs offset weaker sales while the medical- device maker's core heart-rhythm management business continued to weaken.
View more St. Jude Medical 1st-Quarter Profit Rose 5.2% as Lower Costs Offset Revenue Decline analysis
Sign-up for St. Jude Medical 1st-Quarter Profit Rose 5.2% as Lower Costs Offset Revenue Decline investment picks
2013/4/30
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra ™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing options to deliver higher success rates , as evidenced by robust clinical data.
View more St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker analysis
Sign-up for St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker investment picks
2013/5/8
St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced CE Mark approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new portfolio is designed to lower the risk for lead abrasion and to ensure high voltage therapy delivery.
View more St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices analysis
Sign-up for St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices investment picks
2013/5/16
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced CE Mark approval of its ILUMIEN ™ OPTIS ™ PCI Optimization System ™ , a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will be on display for the first time in Europe during EuroPCR.
View more St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement analysis
Sign-up for St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement investment picks
2013/6/11
St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The new devices are designed to lower the risk of lead abrasion and to ensure high-voltage therapy delivery.
View more St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features analysis
Sign-up for St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features investment picks
2013/2/4
St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced the first patient implant of its 25 mm Portico ™ Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.
View more St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial analysis
Sign-up for St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial investment picks
2013/1/30
St. Jude Medical Announces First Patient Enrollment in EnligHTN II Renal Denervation Study
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced enrollment of the first patient in the EnligHTN II trial.
View more St. Jude Medical Announces First Patient Enrollment in EnligHTN II Renal Denervation Study analysis
Sign-up for St. Jude Medical Announces First Patient Enrollment in EnligHTN II Renal Denervation Study investment picks
2013/5/14
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced enrollment of the first patient in the EnligHTN III trial.
View more St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System analysis
Sign-up for St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System investment picks
2013/4/4
St. Jude Medical Announces First Quarter 2013 Earnings Conference Call
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, will hold its quarterly conference call to discuss first quarter 2013 results on Wednesday, April 17, 2013, at 8 a.m. EDT (7 a.m. CDT). This call is being webcast by Thomson Reuters and can be accessed at St.
View more St. Jude Medical Announces First Quarter 2013 Earnings Conference Call analysis
Sign-up for St. Jude Medical Announces First Quarter 2013 Earnings Conference Call investment picks
2013/2/25
St. Jude Medical Announces Increase in Quarterly Dividend
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced that its Board of Directors declared a nine percent increase in the company’s quarterly dividend to $0.25 per common share.
View more St. Jude Medical Announces Increase in Quarterly Dividend analysis
Sign-up for St. Jude Medical Announces Increase in Quarterly Dividend investment picks
2013/3/11
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced the launch of its ILUMIEN ™ OPTIS ™ System, a next-generation technology designed to help physicians make personalized stenting decisions based on each patient’s unique anatomy and disease state.
View more St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan analysis
Sign-up for St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan investment picks
2013/3/21
St. Jude Medical Announces Public Offering of Senior Notes
St. Jude Medical, Inc. (NYSE:STJ) today announced that it has priced an offering to sell $900 million of senior notes due 2023 (the "2023 Notes") and $700 million of senior notes due 2043 (the "2043 Notes"). The 2023 Notes will bear interest at 3.25% per year and, unless previously redeemed, will mature on April 15, 2023.
View more St. Jude Medical Announces Public Offering of Senior Notes analysis
Sign-up for St. Jude Medical Announces Public Offering of Senior Notes investment picks
2013/5/9
St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced the Population Health Research Institute (PHRI), an academic health science research institute, has conducted a further independent analysis of data received from ongoing prospective registries that monitor the performance of the Durata™ and Riata™ ST Optim implantable cardioverter defibrillator (ICD) leads.
View more St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 analysis
Sign-up for St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 investment picks
2013/5/1
St. Jude Medical Announces Second Quarter Dividend
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced that its Board of Directors declared a second quarter dividend of $0.25 per common share.
View more St. Jude Medical Announces Second Quarter Dividend analysis
Sign-up for St. Jude Medical Announces Second Quarter Dividend investment picks
2013/5/21
St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced the start of its landmark EnligHTNment clinical study.
View more St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session analysis
Sign-up for St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session investment picks
2013/5/2
St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced first enrollment of its MultiPoint ™ Pacing clinical study to build upon its first- to-market Quadripolar Pacing System.
View more St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study analysis
Sign-up for St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study investment picks
2013/4/10
St. Jude Medical First to Receive CE Mark Approval of Deep Brain Stimulation Systems for Both Primary and Secondary Dystonia
St. Jude Medical, Inc. (NYSE: STJ) , a global medical device company, today announced European CE Mark approval of its Brio ™ , Libra ™ and Libra XP ™ deep brain stimulation (DBS) systems for managing the symptoms of intractable primary and secondary dystonia , a neurological movement disorder that causes a person’s muscles to contract and involuntarily spasm, reducing the ability to control movement.
View more St. Jude Medical First to Receive CE Mark Approval of Deep Brain Stimulation Systems for Both Primary and Secondary Dystonia analysis
Sign-up for St. Jude Medical First to Receive CE Mark Approval of Deep Brain Stimulation Systems for Both Primary and Secondary Dystonia investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: SSL-built satellite Satmex 8 successfully performs post-launch maneuvers to St. Jude Medical First to Receive CE Mark Approval of Deep Brain Stimulation Systems for Both Primary and Secondary Dystonia
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.